Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2022-08-05 11:13 am Purchase | 13D | STANDARD BIOTOOLS INC. LAB | Caligan Partners LP | 11,444,836 14.8% | 1,021,648 (+9.80%) | View |
| 2022-07-08 4:57 pm Sale | 13G | STANDARD BIOTOOLS INC. LAB | BlackRock Inc. BLK | 2,017,210 2.6% | -4,234,020 (-67.73%) | View |
| 2022-06-07 10:31 am Purchase | 13D | STANDARD BIOTOOLS INC. LAB | Caligan Partners LP | 10,423,188 13.5% | 938,350 (+9.89%) | View |
| 2022-05-03 12:40 pm Purchase | 13D | STANDARD BIOTOOLS INC. LAB | Caligan Partners LP | 9,484,838 12.3% | 1,104,573 (+13.18%) | View |
| 2022-04-14 5:09 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | VIKING GLOBAL INVESTORS LP | 8,103,527 9.5% | 8,103,527 (New Position) | View |
| 2022-04-08 5:07 pm Purchase | 13D | STANDARD BIOTOOLS INC. LAB | Casdin Capital LLC | 37,582,346 32.74% | 37,582,346 (New Position) | View |
| 2022-03-29 5:14 pm Unchanged | 13D | STANDARD BIOTOOLS INC. LAB | Caligan Partners LP | 8,380,265 10.9% | 0 (Unchanged) | View |
| 2022-03-24 4:30 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | RA CAPITAL MANAGEMENT L.P. | 4,651,177 6% | 4,651,177 (New Position) | View |
| 2022-03-07 4:15 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | North Sound Trading LP | 4,375,000 5.7% | 4,375,000 (New Position) | View |
| 2022-02-14 3:46 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | Indaba Capital Management L.P. | 7,585,905 9.9% | 49,555 (+0.66%) | View |
| 2022-02-11 4:39 pm Sale | 13G | STANDARD BIOTOOLS INC. LAB | Russell Investments Group Ltd. | 0 0% | -2,250,881 (Position Closed) | View |
| 2022-02-11 4:21 pm Sale | 13G | STANDARD BIOTOOLS INC. LAB | ORBIMED ADVISORS LLC | 3,416,871 4.46% | -82,375 (-2.35%) | View |
| 2022-02-10 12:24 pm Sale | 13G | STANDARD BIOTOOLS INC. LAB | PRIMECAP MANAGEMENT CO | 5,093,403 6.66% | -340,440 (-6.27%) | View |
| 2022-02-10 08:11 am Purchase | 13G | STANDARD BIOTOOLS INC. LAB | VANGUARD GROUP INC | 3,867,671 5.06% | 391,361 (+11.26%) | View |
| 2022-02-02 7:11 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | BlackRock Inc. BLK | 6,251,230 8.2% | 673,271 (+12.07%) | View |
| 2021-11-18 5:28 pm Sale | 13D | STANDARD BIOTOOLS INC. LAB | Neuberger Berman Group LLC | 4,336,103 5.67% | -308,451 (-6.64%) | View |
| 2021-05-10 5:20 pm Purchase | 13D | STANDARD BIOTOOLS INC. LAB | Caligan Partners LP | 8,380,265 11.2% | 8,380,265 (New Position) | View |
| 2021-02-16 3:33 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | Indaba Capital Management L.P. | 7,536,350 9.9% | 257,826 (+3.54%) | View |
| 2021-02-16 12:35 pm Sale | 13G | STANDARD BIOTOOLS INC. LAB | EASTERLY INVESTMENT PARTNERS LLC | 0 0% | -5,128,573 (Position Closed) | View |
| 2021-02-12 4:46 pm Purchase | 13G | STANDARD BIOTOOLS INC. LAB | ORBIMED ADVISORS LLC | 3,499,246 4.72% | 3,499,246 (New Position) | View |